公司简介

Simphotek provides critical light treatment planning information to physicians using a combination of laser light and light drugs to produce a photo-chemical reaction that kills cancer cells. Light therapy, a.k.a. Photodynamic Therapy, or PDT, is significantly less toxic to the patient compared to conventional cancer therapies and can be repeated as many times as needed as adjunct or prime therapy. The Simphotek team believes that personalized treatment of cancer with light, enabled with its accurate dosimetry, will make PDT a standard alternative cancer cure option offered by cancer treatment facilities.